APO Research
Talk to an analyst

APO RESEARCH · REPORT

Danshen Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Danshen Injection Market Outlook and Growth Opportunities 2026

23 December 2025193 pages

Choose your research edition.

Industry ResearchDanshen Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Danshen Injection Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Danshen Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Danshen Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Danshen Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Danshen Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Danshen Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Danshen Injection market include Changshu Leiyunshang Pharmaceutical, Fujian Gutian Pharmaceutical, Shineway Pharmaceutical, Langch Group, Green Valley Pharma, Sunnyhope Pharmaceutical, HuiKang Pharmaceutical and CHIATAI QINGCHUNBAO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Danshen Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Danshen Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Danshen Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Danshen Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Danshen Injection Segment by Company

Changshu Leiyunshang Pharmaceutical

Fujian Gutian Pharmaceutical

Shineway Pharmaceutical

Langch Group

Green Valley Pharma

Sunnyhope Pharmaceutical

HuiKang Pharmaceutical

CHIATAI QINGCHUNBAO

Danshen Injection Segment by Type

2ml Per Tube

10ml Per Tube

Danshen Injection Segment by Application

Tertiary Hospital

Secondary Hospital

Others

Danshen Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Danshen Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Danshen Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Danshen Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Danshen Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Danshen Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Danshen Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Danshen Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Danshen Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Danshen Injection industry.

Chapter 3: Detailed analysis of Danshen Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Danshen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Danshen Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Danshen Injection Industry Trends Table 2. Danshen Injection Industry Drivers Table 3. Danshen Injection Industry Opportunities and Challenges Table 4. Danshen Injection Industry Restraints Table 5. Global Danshen Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Danshen Injection Revenue Share by Company (2021-2026) Table 7. Global Danshen Injection Sales Volume by Company (k units) & (2021-2026) Table 8. Global Danshen Injection Sales Volume Share by Company (2021-2026) Table 9. Global Danshen Injection Average Price (USD/unit) of Company (2021-2026) Table 10. Global Danshen Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Danshen Injection Key Company Manufacturing Base & Headquarters Table 12. Global Danshen Injection Company, Product Type & Application Table 13. Global Danshen Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Danshen Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 2ml Per Tube Table 18. Significant Companies of 10ml Per Tube Table 19. Global Danshen Injection Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Danshen Injection Sales Volume by Type (2021-2026) & (k units) Table 21. Global Danshen Injection Sales Volume by Type (2027-2032) & (k units) Table 22. Global Danshen Injection Sales Volume Share by Type (2021-2026) Table 23. Global Danshen Injection Sales Volume Share by Type (2027-2032) Table 24. Global Danshen Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Danshen Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Danshen Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Danshen Injection Sales Value Share by Type (2021-2026) Table 28. Global Danshen Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Tertiary Hospital Table 30. Significant Companies of Secondary Hospital Table 31. Significant Companies of Others Table 32. Global Danshen Injection Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Danshen Injection Sales Volume by Application (2021-2026) & (k units) Table 34. Global Danshen Injection Sales Volume by Application (2027-2032) & (k units) Table 35. Global Danshen Injection Sales Volume Share by Application (2021-2026) Table 36. Global Danshen Injection Sales Volume Share by Application (2027-2032) Table 37. Global Danshen Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Danshen Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Danshen Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Danshen Injection Sales Value Share by Application (2021-2026) Table 41. Global Danshen Injection Sales Value Share by Application (2027-2032) Table 42. Global Danshen Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Danshen Injection Sales by Region (2021-2026) & (k units) Table 44. Global Danshen Injection Sales Market Share by Region (2021-2026) Table 45. Global Danshen Injection Sales by Region (2027-2032) & (k units) Table 46. Global Danshen Injection Sales Market Share by Region (2027-2032) Table 47. Global Danshen Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Danshen Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Danshen Injection Sales Value Share by Region (2021-2026) Table 50. Global Danshen Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Danshen Injection Sales Value Share by Region (2027-2032) Table 52. Global Danshen Injection Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Danshen Injection Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Danshen Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Danshen Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Danshen Injection Sales by Country (2021-2026) & (k units) Table 57. Global Danshen Injection Sales Market Share by Country (2021-2026) Table 58. Global Danshen Injection Sales by Country (2027-2032) & (k units) Table 59. Global Danshen Injection Sales Market Share by Country (2027-2032) Table 60. Global Danshen Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Danshen Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Danshen Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Danshen Injection Sales Value Market Share by Country (2027-2032) Table 64. Changshu Leiyunshang Pharmaceutical Company Information Table 65. Changshu Leiyunshang Pharmaceutical Business Overview Table 66. Changshu Leiyunshang Pharmaceutical Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Changshu Leiyunshang Pharmaceutical Danshen Injection Product Portfolio Table 68. Changshu Leiyunshang Pharmaceutical Recent Development Table 69. Fujian Gutian Pharmaceutical Company Information Table 70. Fujian Gutian Pharmaceutical Business Overview Table 71. Fujian Gutian Pharmaceutical Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Fujian Gutian Pharmaceutical Danshen Injection Product Portfolio Table 73. Fujian Gutian Pharmaceutical Recent Development Table 74. Shineway Pharmaceutical Company Information Table 75. Shineway Pharmaceutical Business Overview Table 76. Shineway Pharmaceutical Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Shineway Pharmaceutical Danshen Injection Product Portfolio Table 78. Shineway Pharmaceutical Recent Development Table 79. Langch Group Company Information Table 80. Langch Group Business Overview Table 81. Langch Group Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Langch Group Danshen Injection Product Portfolio Table 83. Langch Group Recent Development Table 84. Green Valley Pharma Company Information Table 85. Green Valley Pharma Business Overview Table 86. Green Valley Pharma Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Green Valley Pharma Danshen Injection Product Portfolio Table 88. Green Valley Pharma Recent Development Table 89. Sunnyhope Pharmaceutical Company Information Table 90. Sunnyhope Pharmaceutical Business Overview Table 91. Sunnyhope Pharmaceutical Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Sunnyhope Pharmaceutical Danshen Injection Product Portfolio Table 93. Sunnyhope Pharmaceutical Recent Development Table 94. HuiKang Pharmaceutical Company Information Table 95. HuiKang Pharmaceutical Business Overview Table 96. HuiKang Pharmaceutical Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. HuiKang Pharmaceutical Danshen Injection Product Portfolio Table 98. HuiKang Pharmaceutical Recent Development Table 99. CHIATAI QINGCHUNBAO Company Information Table 100. CHIATAI QINGCHUNBAO Business Overview Table 101. CHIATAI QINGCHUNBAO Danshen Injection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. CHIATAI QINGCHUNBAO Danshen Injection Product Portfolio Table 103. CHIATAI QINGCHUNBAO Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Danshen Injection Distributors List Table 107. Danshen Injection Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Danshen Injection Product Image Figure 2. Global Danshen Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Danshen Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Danshen Injection Sales (2021-2032) & (k units) Figure 5. Global Danshen Injection Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Danshen Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 2ml Per Tube Image Figure 10. 10ml Per Tube Image Figure 11. Global Danshen Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Danshen Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Danshen Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Danshen Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Danshen Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Danshen Injection Sales Value Share by Type (2021-2032) Figure 17. Tertiary Hospital Image Figure 18. Secondary Hospital Image Figure 19. Others Image Figure 20. Global Danshen Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Danshen Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Danshen Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Danshen Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Danshen Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Danshen Injection Sales Value Share by Application (2021-2032) Figure 26. Global Danshen Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Danshen Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Danshen Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Danshen Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Danshen Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Danshen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Danshen Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Danshen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Danshen Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Danshen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Danshen Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Danshen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Danshen Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Danshen Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Danshen Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Danshen Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Danshen Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Danshen Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Danshen Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 2ml Per Tube
  • 10ml Per Tube
Applications
  • Tertiary Hospital
  • Secondary Hospital
  • Others
Companies covered
  • Changshu Leiyunshang Pharmaceutical
  • Fujian Gutian Pharmaceutical
  • Shineway Pharmaceutical
  • Langch Group
  • Green Valley Pharma
  • Sunnyhope Pharmaceutical
  • HuiKang Pharmaceutical
  • CHIATAI QINGCHUNBAO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Danshen Injection Sales Value (2021-2032)
  4. 1.2.2 Global Danshen Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Danshen Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Danshen Injection Market Dynamics
  1. 2.1 Danshen Injection Industry Trends
  2. 2.2 Danshen Injection Industry Drivers
  3. 2.3 Danshen Injection Industry Opportunities and Challenges
  4. 2.4 Danshen Injection Industry Restraints
3 Danshen Injection Market by Company
  1. 3.1 Global Danshen Injection Company Revenue Ranking in 2025
  2. 3.2 Global Danshen Injection Revenue by Company (2021-2026)
  3. 3.3 Global Danshen Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Danshen Injection Average Price by Company (2021-2026)
  5. 3.5 Global Danshen Injection Company Ranking (2024-2026)
  6. 3.6 Global Danshen Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Danshen Injection Company Product Type and Application
  8. 3.8 Global Danshen Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Danshen Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Danshen Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Danshen Injection Market by Type
  1. 4.1 Danshen Injection Type Introduction
  2. 4.1.1 2ml Per Tube
  3. 4.1.2 10ml Per Tube
  4. 4.2 Global Danshen Injection Sales Volume by Type
  5. 4.2.1 Global Danshen Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Danshen Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Danshen Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Danshen Injection Sales Value by Type
  9. 4.3.1 Global Danshen Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Danshen Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Danshen Injection Sales Value Share by Type (2021-2032)
5 Danshen Injection Market by Application
  1. 5.1 Danshen Injection Application Introduction
  2. 5.1.1 Tertiary Hospital
  3. 5.1.2 Secondary Hospital
  4. 5.1.3 Others
  5. 5.2 Global Danshen Injection Sales Volume by Application
  6. 5.2.1 Global Danshen Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Danshen Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Danshen Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Danshen Injection Sales Value by Application
  10. 5.3.1 Global Danshen Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Danshen Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Danshen Injection Sales Value Share by Application (2021-2032)
6 Danshen Injection Regional Sales and Value Analysis
  1. 6.1 Global Danshen Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Danshen Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Danshen Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Danshen Injection Sales by Region (2027-2032)
  5. 6.3 Global Danshen Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Danshen Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Danshen Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Danshen Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Danshen Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Danshen Injection Sales Value (2021-2032)
  12. 6.6.2 North America Danshen Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Danshen Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Danshen Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Danshen Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Danshen Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Danshen Injection Sales Value (2021-2032)
  21. 6.9.2 South America Danshen Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Danshen Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Danshen Injection Sales Value Share by Country, 2025 VS 2032
7 Danshen Injection Country-level Sales and Value Analysis
  1. 7.1 Global Danshen Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Danshen Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Danshen Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Danshen Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Danshen Injection Sales by Country (2027-2032)
  6. 7.4 Global Danshen Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Danshen Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Danshen Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Danshen Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Danshen Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Danshen Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Danshen Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Danshen Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Danshen Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Danshen Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Danshen Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Danshen Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Danshen Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Danshen Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Danshen Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Danshen Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Danshen Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Danshen Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Danshen Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Danshen Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Danshen Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Danshen Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Danshen Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Danshen Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Danshen Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Danshen Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Danshen Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Danshen Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Danshen Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Danshen Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Danshen Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Danshen Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Danshen Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Danshen Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Danshen Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Danshen Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Danshen Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Danshen Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Danshen Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Danshen Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Danshen Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Danshen Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Danshen Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Danshen Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Danshen Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Danshen Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Danshen Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Danshen Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Danshen Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Danshen Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Danshen Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Danshen Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Danshen Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Danshen Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Danshen Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Danshen Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Danshen Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Danshen Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Danshen Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Danshen Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Danshen Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Danshen Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Danshen Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Danshen Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Danshen Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Danshen Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Danshen Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Danshen Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Danshen Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Danshen Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Danshen Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Danshen Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Danshen Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Danshen Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Danshen Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Danshen Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Danshen Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Danshen Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Danshen Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Danshen Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Danshen Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Danshen Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Danshen Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Danshen Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Danshen Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Danshen Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Danshen Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Changshu Leiyunshang Pharmaceutical
  2. 8.1.1 Changshu Leiyunshang Pharmaceutical Company Information
  3. 8.1.2 Changshu Leiyunshang Pharmaceutical Business Overview
  4. 8.1.3 Changshu Leiyunshang Pharmaceutical Danshen Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Changshu Leiyunshang Pharmaceutical Danshen Injection Product Portfolio
  6. 8.1.5 Changshu Leiyunshang Pharmaceutical Recent Developments
  7. 8.2 Fujian Gutian Pharmaceutical
  8. 8.2.1 Fujian Gutian Pharmaceutical Company Information
  9. 8.2.2 Fujian Gutian Pharmaceutical Business Overview
  10. 8.2.3 Fujian Gutian Pharmaceutical Danshen Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fujian Gutian Pharmaceutical Danshen Injection Product Portfolio
  12. 8.2.5 Fujian Gutian Pharmaceutical Recent Developments
  13. 8.3 Shineway Pharmaceutical
  14. 8.3.1 Shineway Pharmaceutical Company Information
  15. 8.3.2 Shineway Pharmaceutical Business Overview
  16. 8.3.3 Shineway Pharmaceutical Danshen Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shineway Pharmaceutical Danshen Injection Product Portfolio
  18. 8.3.5 Shineway Pharmaceutical Recent Developments
  19. 8.4 Langch Group
  20. 8.4.1 Langch Group Company Information
  21. 8.4.2 Langch Group Business Overview
  22. 8.4.3 Langch Group Danshen Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Langch Group Danshen Injection Product Portfolio
  24. 8.4.5 Langch Group Recent Developments
  25. 8.5 Green Valley Pharma
  26. 8.5.1 Green Valley Pharma Company Information
  27. 8.5.2 Green Valley Pharma Business Overview
  28. 8.5.3 Green Valley Pharma Danshen Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Green Valley Pharma Danshen Injection Product Portfolio
  30. 8.5.5 Green Valley Pharma Recent Developments
  31. 8.6 Sunnyhope Pharmaceutical
  32. 8.6.1 Sunnyhope Pharmaceutical Company Information
  33. 8.6.2 Sunnyhope Pharmaceutical Business Overview
  34. 8.6.3 Sunnyhope Pharmaceutical Danshen Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sunnyhope Pharmaceutical Danshen Injection Product Portfolio
  36. 8.6.5 Sunnyhope Pharmaceutical Recent Developments
  37. 8.7 HuiKang Pharmaceutical
  38. 8.7.1 HuiKang Pharmaceutical Company Information
  39. 8.7.2 HuiKang Pharmaceutical Business Overview
  40. 8.7.3 HuiKang Pharmaceutical Danshen Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 HuiKang Pharmaceutical Danshen Injection Product Portfolio
  42. 8.7.5 HuiKang Pharmaceutical Recent Developments
  43. 8.8 CHIATAI QINGCHUNBAO
  44. 8.8.1 CHIATAI QINGCHUNBAO Company Information
  45. 8.8.2 CHIATAI QINGCHUNBAO Business Overview
  46. 8.8.3 CHIATAI QINGCHUNBAO Danshen Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 CHIATAI QINGCHUNBAO Danshen Injection Product Portfolio
  48. 8.8.5 CHIATAI QINGCHUNBAO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Danshen Injection Value Chain Analysis
  2. 9.1.1 Danshen Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Danshen Injection Sales Mode & Process
  6. 9.2 Danshen Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Danshen Injection Distributors
  9. 9.2.3 Danshen Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst